NS7-78001-88185
4 vaccinations
1 coded response
43 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 762 / TX
- Registered
- 2020-12-27
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QLK-23557-59331
Child or adolescent in my care · Male · 2022-10-06
Timeline
-
2020-12-27
Registered in v-safe
-
2020-12-27
Dose 1 — Moderna
- 2020-12-27
-
2020-12-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · HeadacheAdult check-in
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-10
- 2021-01-17
-
2021-01-24
Dose 2 — Moderna
- 2021-01-24
- 2021-01-25
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Fatigue or tirednessAdult check-in
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-29
- 2021-01-31
- 2021-02-07
- 2021-02-14
- 2021-02-22
- 2021-02-28
- 2021-03-07
- 2021-04-25
- 2021-07-25
-
2021-11-15
Dose 3 — Moderna
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-30
- 2021-12-06
- 2021-12-13
- 2021-12-20
- 2021-12-27
-
2022-02-16
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid-19MedDRA releases: 2024-11 · check-in free text available
-
2022-02-16
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-17
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-05-16
-
2022-10-04
Dose 4 — Moderna
- 2022-10-06
- 2022-10-08
- 2022-10-11
- 2022-11-17
- 2023-01-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-27 | Moderna | |
| 2 | 2021-01-24 | Moderna | |
| 3 | 2021-11-15 | Moderna | No |
| 4 | 2022-10-04 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 3 months, dose 3
Symptoms: Covid-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release